ADVANCED/RECURRENT OVARIAN CANCER

Clinical trials for ADVANCED/RECURRENT OVARIAN CANCER explained in plain language.

Never miss a new study

Get alerted when new ADVANCED/RECURRENT OVARIAN CANCER trials appear

Sign up with your email to follow new studies for ADVANCED/RECURRENT OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Targeted attack on ovarian cancer halted before launch

Disease control Terminated

This early-stage trial aimed to test a new, targeted drug called saruparib for women with advanced or recurrent ovarian cancer who have specific genetic changes (BRCA mutations). The goal was to see if the drug was safe and showed early signs of shrinking tumors before planned su…

Matched conditions: ADVANCED/RECURRENT OVARIAN CANCER

Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

ADVANCED/RECURRENT OVARIAN CANCER

Get alerted when new ADVANCED/RECURRENT OVARIAN CANCER trials appear

Targeted attack on ovarian cancer halted before launch